Phase 2 Clinical Trial for Marburg Vaccine Starts in Uganda Medical Countermeasures October 19, 2023 …
Novavax’s Prototype COVID-19 Vaccine Nuvaxovid Receives Full Approval in Singapore Medical Countermeasures October 18, 2023 …
Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster Medical Countermeasures September 20, 2023 …
Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant Contracts + Grants September 17, 2023 …
NIAID Seeks to Improve Computational Models of Influenza Immunity Contracts + Grants September 15, 2023 …
Kyasanur Forest Disease: Promising Experimental Vaccine for Rare Tick-borne Flavivirus Medical Countermeasures September 7, 2023 …
Disease X: CEPI and University of Oxford Collaborate on Rapid Response Vaccine Technology Medical Countermeasures August 29, 2023 …
Research Ramps Up to Mitigate Surging Syphilis Rates in the U.S. Infectious Diseases August 29, 2023 …
Chikungunya Vaccine: Health Canada Moves Forward with Valneva Review Medical Countermeasures August 29, 2023 …
Allucent Awarded BARDA Contract to Accelerate Next-Generation COVID-19 Booster Vaccines Medical Countermeasures August 28, 2023 …
NIAID Study Shows Low-Dose Marburg Vaccine Effective in Macaques Medical Countermeasures August 25, 2023 …
Imunon Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus Industry News August 24, 2023 …
Project NextGen: HHS Awards $1.4B for COVID Countermeasure Development Contracts + Grants August 22, 2023 …
Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine Medical Countermeasures July 20, 2023 …
DARPA Selects Teams to Develop Vaccine Durability Prediction Model Medical Countermeasures January 13, 2023 …
